Research map: Patterns of progression and efficacy of immune checkpoint inhibitors in unresectable, recurrent, or metastatic cholangiocarcinoma: A real-world study

Back to the article

Papers in this map

  1. New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1) · E. A. Eisenhauer · 2008 · 30146 citations · Cited by this paper
  2. Laparoscopy-assisted mesenteric vein access for portal vein recanalization and Transjugular intrahepatic portosystemic shunt: A novel TIPS approach for cavernous transformation of the portal vein · 2026 · Related
  3. Cholangiocarcinoma 2020: the next horizon in mechanisms and management · Jesús M. Bañales · 2020 · 2542 citations · Cited by this paper
  4. Author’s reply: “Fibrate therapy in primary sclerosing cholangitis" · 2026 · Related
  5. Immunogenic cell stress and death · Guido Kroemer · 2022 · 1354 citations · Cited by this paper
  6. The “starry sky” sign of intrahepatic biliary hamartoma · 2026 · Related
  7. Durvalumab plus Gemcitabine and Cisplatin in Advanced Biliary Tract Cancer · Do‐Youn Oh · 2022 · 1210 citations · Cited by this paper
  8. Double immunohistochemistry to detect transglutaminase 2-IgA deposits in celiac children: a multicentre study · 2026 · Related
  9. Pembrolizumab in combination with gemcitabine and cisplatin compared with gemcitabine and cisplatin alone for patients with advanced biliary tract cancer (KEYNOTE-966): a randomised, double-blind, placebo-controlled, phase 3 trial · Robin Kate Kelley · 2023 · 1156 citations · Cited by this paper
  10. A Solitary solid-appearing multicystic bile duct hamartoma mimicking hepatocellular carcinoma · 2026 · Related
  11. Local consolidative therapy versus maintenance therapy or observation for patients with oligometastatic non-small-cell lung cancer without progression after first-line systemic therapy: a multicentre, randomised, controlled, phase 2 study · Daniel Richard Gomez · 2016 · 1104 citations · Cited by this paper
  12. Pharmacovigilance of drug-induced microscopic colitis: time to consider exposure duration and dechallenge completeness · 2026 · Related
  13. Liver metastasis restrains immunotherapy efficacy via macrophage-mediated T cell elimination · Jiali Yu · 2021 · 1030 citations · Cited by this paper
  14. Long-term add-on fibrate therapy in Primary Sclerosing Cholangitis: Safety, biochemical response, and disease progression · 2026 · Related
  15. Roles of CA19-9 in pancreatic cancer: Biomarker, predictor and promoter · Guopei Luo · 2020 · 459 citations · Cited by this paper
  16. Hepatic portal venous gas: An ominous sign of death · 2026 · Related
  17. Hepatic Arterial Infusion of Oxaliplatin, Fluorouracil, and Leucovorin Versus Transarterial Chemoembolization for Large Hepatocellular Carcinoma: A Randomized Phase III Trial · Qi-Jiong Li · 2021 · 435 citations · Cited by this paper
  18. A multimodal artificial intelligence method for accurate diagnosis of autoimmune gastritis · 2026 · Related
  19. Reprogramming of glucose metabolism in hepatocellular carcinoma: Progress and prospects · Runze Shang · 2016 · 183 citations · Cited by this paper
  20. Pattern-based histologic approach in colitis without chronic architectural damage: GIPAD recommendations · 2026 · Related
  21. Epidemiology of cholangiocarcinoma · Maria Qurashi · 2023 · 165 citations · Cited by this paper
  22. How I treat biliary tract cancer · Ángela Lamarca · 2022 · 142 citations · Cited by this paper
  23. Immunobiology of cholangiocarcinoma · Emilien J. Loeuillard · 2019 · 127 citations · Cited by this paper
  24. Association of KRAS Variant Subtypes With Survival and Recurrence in Patients With Surgically Treated Intrahepatic Cholangiocarcinoma · Shao‐Lai Zhou · 2021 · 70 citations · Cited by this paper
  25. Heterogeneity of Cholangiocarcinoma Immune Biology · Francesca Vita · 2023 · 33 citations · Cited by this paper
  26. Biliary tract cancer · Kjetil Søreide · 2024 · 28 citations · Cited by this paper
  27. CA19.9 decrease >15% is a predictor of favourable outcome in patients treated for advanced pancreatic carcinoma: analysis of two independent cohorts · Lucie Laurent · 2018 · 21 citations · Cited by this paper
  28. Mobilization and activation of tumor-infiltrating dendritic cells inhibits lymph node metastasis in intrahepatic cholangiocarcinoma · Bao‐Ye Sun · 2024 · 20 citations · Cited by this paper
  29. Revealing the Heterogeneity of the Tumor Ecosystem of Cholangiocarcinoma through Single-Cell Transcriptomics · Jihye L. Golino · 2023 · 14 citations · Cited by this paper
  30. Strategies for treating the cold tumors of cholangiocarcinoma: core concepts and future directions · GuanBo Zhang · 2024 · 13 citations · Cited by this paper
  31. Patterns of Failure in Patients With Advanced Non-Small Cell Lung Cancer Treated With Immune Checkpoint Inhibitors · Rong Chai · 2021 · 7 citations · Cited by this paper
  32. Immunotherapy in biliary tract cancer: reshaping the tumour microenvironment and advancing precision combination strategies · Jingnan Xue · 2025 · 6 citations · Cited by this paper
  33. Metastatic sites and lesion numbers cooperated to predict efficacy of PD ‐1 inhibitor‐based combination therapy for patients with metastatic colorectal cancer · Weiqin Jiang · 2023 · 5 citations · Cited by this paper
  34. The association of carbohydrate antigen 19‐9 response with radiologic response and survival in intrahepatic cholangiocarcinoma: A prospective cohort study · Quan‐Yu Cai · 2023 · 5 citations · Cited by this paper
  35. Patterns of failure and the subsequent treatment after progression on first-line immunotherapy monotherapy in advanced non-small cell lung cancer: a retrospective study · Jia‐Yi Deng · 2024 · 5 citations · Cited by this paper
  36. Locoregional therapy combined with systemic therapy (LRT + ST) for unresectable and metastatic intrahepatic cholangiocarcinoma: a systematic review and meta-analysis · Mengqi Zhang · 2023 · 3 citations · Cited by this paper
  37. Untitled · Cited by this paper
  38. Untitled · Cited by this paper
  39. Untitled · Cited by this paper

Source: OpenAlex (CC0)